Stay updated on Zenocutuzumab Clinical Trial in NRG1 Fusion
Sign up to get notified when there's something new on the Zenocutuzumab Clinical Trial in NRG1 Fusion page.

Latest updates to the Zenocutuzumab Clinical Trial in NRG1 Fusion page
- Check5 days agoChange DetectedAdded: Revision: v3.4.2. Deleted: the government funding lapse notice and Revision: v3.4.1. The study details and eligibility criteria remain unchanged.SummaryDifference0.3%

- Check12 days agoChange DetectedA global notice about government funding lapse and NIH Clinical Center operating status was added, directing users to official sources for updates. The page revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check19 days agoChange DetectedThe update adds a glossary display, updates QC-related metadata (Last Update Submitted that Met QC Criteria) and the revision version (v3.4.0), and removes an older QC entry and the No FEAR Act data label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedRevision indicator updated from v3.3.3 to v3.3.4. This is a minor, non-content change that does not affect the study information displayed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check54 days agoChange DetectedA consolidated Locations section was added, listing study sites across the United States, Ontario, and Singapore, replacing the prior per-state location entries.SummaryDifference1%

- Check76 days agoChange DetectedA minor revision label updated from v3.3.1 to v3.3.2 on the page; no changes to study content or critical information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Zenocutuzumab Clinical Trial in NRG1 Fusion
Enter your email address, and we'll notify you when there's something new on the Zenocutuzumab Clinical Trial in NRG1 Fusion page.